Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
phase_1_2
1 (50.0%)Phase 2
1 (50.0%)A Study of Oncobax®-AK in Patients With Advanced Solid Tumors
Phase 2
Recruiting
- Conditions
- Carcinoma, Renal CellCarcinoma, Non-Small-Cell Lung
- First Posted Date
- 2023-05-19
- Last Posted Date
- 2023-05-19
- Lead Sponsor
- EverImmune
- Target Recruit Count
- 122
- Registration Number
- NCT05865730
- Locations
- 🇧🇪
CHU Ambroise Paré, Mons, Belgium
🇫🇷Centre Georges Francois Leclerc, Dijon, France
🇫🇷Institut Gustave Roussy, Paris, France
News
No news found